Andrew S. Kitzmiller

VP, CAO and Controller, Hillenbrand, Inc.

Companies

Meridian BioscienceChief financial officer Feb 22, 2022 to Jan 31, 2023¹
Hillenbrand, Inc.VP, CAO and Controller Dec 2, 2019 to Jan 4, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Meridian Bioscience0 shares³Jan 31, 2023
Hillenbrand, Inc. HI4,886 shares⁴Jan 4, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 31, 2023Returned to company 19,473 shares of Meridian Bioscience³
Jan 31, 2023Granted 7,945 shares of Meridian Bioscience³
Feb 25, 2022Bought 4,028 shares at $24.87 of Meridian Bioscience⁵
Feb 21, 2022Granted 7,500 shares of Meridian Bioscience⁶
Dec 5, 2021Shares withheld for tax 476 shares at $47.11 of Hillenbrand, Inc.⁷
Dec 5, 2021Exercised options 1,095 shares of Hillenbrand, Inc.⁷
Dec 3, 2021Shares withheld for tax 384 shares at $47.11 of Hillenbrand, Inc.⁷
Dec 3, 2021Exercised options 884 shares of Hillenbrand, Inc.⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMeridian Bioscience, Chief financial officer
2
SEC EDGARHillenbrand, Inc., VP, CAO and Controller
3
SEC EDGARMeridian Bioscience shares after the filing of Jan 31, 2023
4
SEC EDGARHillenbrand, Inc. shares after the filing of Jan 4, 2022
5
SEC EDGARForm 4 filed Feb 28, 2022
6
SEC EDGARForm 4 filed Feb 22, 2022
7
SEC EDGARForm 4 filed Dec 7, 2021